http://www.modernmedicine.com/modernmedicine/Prostate+Cancer/Article/list/40237 Clinical information, articles, medical news and research concerning Prostate Cancer. Diagnosis and treatment information including decision support tools for formulary and ICD-9 codes. 2009-11-21T21:30:56Z http://www.modernmedicine.com/modernmedicine/Enews/New-finding-suggests-prostate-biopsy-is-not-always/ArticleStandard/Article/detail/641757?contextCategoryId=40237&ref=25 Some elevated PSA levels in men may be caused by a normally occurring hormone and are not necessarily a predictor of the need for a prostate biopsy, according to results of a recently published study. 2009-11-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/462009/641757null HTML http://www.modernmedicine.com/modernmedicine/Enews/AUA-clarifies-recommendations-on-early-prostate-ca/ArticleStandard/Article/detail/641755?contextCategoryId=40237&ref=25 Despite recent news reports disparaging prostate cancer testing, early detection of the disease remains in the best interest of the patient, according to an AUA statement clarifying its testing recommendations. 2009-11-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/462009/641755null HTML http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Nervous-System-Cancer-Linked-to-Cognitive-Impairme/ArticleNewsFeed/Article/detail/642028?contextCategoryId=40237&ref=25 Survivors of childhood central nervous system cancers are more likely to report reduced neurocognitive function resulting in lower education, employment and income in adulthood than survivors of other cancers, according to a study in the November issue of Neuropsychology. 2009-11-16T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642028/BRAINsmall.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642028null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Exercise-Linked-to-Less-Risk-of-High-Grade-Prostat/ArticleNewsFeed/Article/detail/641793?contextCategoryId=40237&ref=25 Exercise was associated with lower risk of prostate cancer upon biopsy, as well as lower risk of high-grade disease in those with cancer, and African-American men with increased low-density lipoprotein showed a higher likelihood of prostate cancer diagnosis, according to two studies in the November issue of The Journal of Urology. 2009-11-13T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641793/workout.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/641793null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Earlier-Prostate-Specific-Antigen-Testing-Suggeste/ArticleNewsFeed/Article/detail/640828?contextCategoryId=40237&ref=25 The optimal use of prostate specific antigen for early detection of prostate cancer, risk stratification, and post-treatment management is the focus of an article published in the November issue of The Journal of Urology. 2009-11-10T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640828/confusedman.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640828null XML http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Arthritis-Drugs-Unlikely-to-Increase-Cancer-Risk/ArticleNewsFeed/Article/detail/640420?contextCategoryId=40237&ref=25 Rheumatoid arthritis patients who start taking anti-tumor necrosis factor α drugs are not likely to have a higher risk of developing cancer than other groups of rheumatoid arthritis patients, according to a Swedish study in the November issue of Arthritis & Rheumatism. 2009-11-09T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640420/ARTHRITIS.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/462009/640420null XML http://www.modernmedicine.com/modernmedicine/Enews/New-technology-picks-up-undetectable-PSA-levels/ArticleStandard/Article/detail/638111?contextCategoryId=40237&ref=25 Using an extremely sensitive tool based on nanotechnology, researchers from Northwestern University, Chicago say they have detected previously undetectable levels of PSA in patients who have undergone radical prostatectomy. 2009-11-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/638111null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Cholesterol-May-Decrease-Cancer-Risk/ArticleNewsFeed/Article/detail/639482?contextCategoryId=40237&ref=25 Two studies published online Nov. 3 in Cancer Epidemiology, Biomarkers & Prevention may dissolve the long standing concern that low cholesterol levels may lead to a higher risk of cancer. 2009-11-04T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639482/blood_MIC023ML.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/639482null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/ASTRO-Combination-Therapy-Beneficial-in-Prostate-C/ArticleNewsFeed/Article/detail/638901?contextCategoryId=40237&ref=25 Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago. 2009-11-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638901/proscancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638901null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-cancer-radiation-therapy-may-increase-rec/ArticleStandard/Article/detail/637929?contextCategoryId=40237&ref=25 Compared with the general population, prostate cancer patients treated with radiation therapy were almost twice as likely to develop rectal cancer. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637929null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Robot-assisted-radical-prostatectomy-Recent-techni/ArticleStandard/Article/detail/637931?contextCategoryId=40237&ref=25 Since the original description of the robot-assisted laparoscopic prostatectomy technique in 2002, several technical modifications have been reported. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637931null XML http://urologytimes.modernmedicine.com/urologytimes/Prostate+Cancer/Low-risk-prostate-cancer-well-managed-with-active-/ArticleStandard/Article/detail/638692?contextCategoryId=40237&ref=25 Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/452009/638692null REMOTE http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-risk-prostate-cancer-well-managed-with-active-/ArticleStandard/Article/detail/637932?contextCategoryId=40237&ref=25 Patients in active surveillance for prostate cancer were almost 20 times more likely to die of causes other than prostate cancer. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637932null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Robotic-prostatectomy-safe-in-obese-patients/ArticleStandard/Article/detail/637944?contextCategoryId=40237&ref=25 Robotic prostatectomy in morbidly obese men is feasible, reasonably safe, and appears to provide oncologic control comparable to that achieved in a normal weight population. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637944null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Benign-PSA-enhances-prostate-cancer-detection/ArticleStandard/Article/detail/637942?contextCategoryId=40237&ref=25 Benign PSA, measured in serum with a proprietary automated assay, improves prostate cancer detection when it is incorporated into an artificial neural network. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637942null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Diabetes-found-to-protect-against-prostate-cancer/ArticleStandard/Article/detail/637928?contextCategoryId=40237&ref=25 A diagnosis of diabetes or cardiometabolic disorders was not associated with an increased risk of incident prostate cancer, but rather a decreased incidence of the disease. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637928null XML http://urologytimes.modernmedicine.com/urologytimes/News/Diabetes-found-to-protect-against-prostate-cancer/ArticleStandard/Article/detail/638682?contextCategoryId=40237&ref=25 Cardiometabolic disorders and urologic disease represent a "perfect storm" of ailments, according to Kevin T. McVary, MD, who discusses the urologist's role in management. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/452009/638682null REMOTE http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-radical-prostatectomy-PDE-5-therapy-speeds-er/ArticleStandard/Article/detail/637933?contextCategoryId=40237&ref=25 Postoperative pharmacologic therapy enhances the chances of erectile function recovery in virtually all categories of men who undergo bilateral nerve-sparing prostatectomy. 2009-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/442009/637933null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Endorectal-Imaging-Benefit-Seen-in-Prostate-Cancer/ArticleNewsFeed/Article/detail/638147?contextCategoryId=40237&ref=25 Endorectal magnetic resonance imaging may be useful in categorizing men with stage T1c prostate cancer for proper treatment management, according to research published in the November issue of Radiology. 2009-10-30T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/638147/balding_fac088.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/638147null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-Specific-Antigen-Velocity-Linked-to-Morta/ArticleNewsFeed/Article/detail/637807?contextCategoryId=40237&ref=25 Men with unfavorable prostate cancer whose prostate-specific antigen levels rapidly increase at recurrence have a higher risk of death, but only if they have no or minimal comorbidities, according to a study published online Oct. 26 in the Journal of Clinical Oncology. 2009-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637807/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637807null XML http://www.modernmedicine.com/modernmedicine/Enews/Minimally-invasive-RP-shows-some-advantages-but-ce/ArticleStandard/Article/detail/636232?contextCategoryId=40237&ref=25 Minimally invasive procedures for radical prostatectomy, including robotic assistance, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to findings from a recent study. 2009-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/432009/636232null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vessel-Type-Linked-to-Disease-Severity-in-Prostate/ArticleNewsFeed/Article/detail/637806?contextCategoryId=40237&ref=25 Men with prostate tumors whose vascular supply consists of vessels with primitive morphology are more likely to develop lethal disease, according to a study published online Oct. 26 in the Journal of Clinical Oncology. 2009-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637806/proscancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442009/637806null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Researchers-Evaluate-New-Prostate-Specific-Antigen/ArticleNewsFeed/Article/detail/636333?contextCategoryId=40237&ref=25 A new test for prostate-specific antigen levels is considerably more sensitive than commercial assays and allows better monitoring for recurrence after prostatectomy for early-stage prostate cancer, according to a study published online Oct. 19 in the Proceedings of the National Academy of Sciences. 2009-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636333/Mic093ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636333null XML http://www.modernmedicine.com/modernmedicine/Gynecologic+Oncology/Neonatal-Outcomes-Examined-in-Cancer-Pregnancies/ArticleNewsFeed/Article/detail/636218?contextCategoryId=40237&ref=25 Pregnancies in women with cancer tend to have good outcomes overall, but have been associated with high rates of induced labor and newborn admission to a neonatal intensive care unit, according to a study published online Oct. 19 in the Journal of Clinical Oncology. 2009-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636218/hospital_room.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636218null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Radiation-for-Prostate-Linked-to-Later-Pelvic-Canc/ArticleNewsFeed/Article/detail/636103?contextCategoryId=40237&ref=25 Radiation following radical surgery for prostate cancer may increase the risk of late primary pelvic second primary cancer, according to research published in the October issue of Urology. 2009-10-22T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636103/stressedvet.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636103null XML http://www.modernmedicine.com/modernmedicine/Enews/Dutasteride-maker-files-NDA-for-prostate-cancer-ri/ArticleStandard/Article/detail/633449?contextCategoryId=40237&ref=25 p>GlaxoSmithKline has filed a supplemental new drug application with the FDA for dutasteride (Avodart) for prostate cancer risk reduction among men at increased risk of developing the disease. 2009-10-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633449null HTML http://www.modernmedicine.com/modernmedicine/Enews/Large-scale-study-PCa-patients-on-hormone-therapy-/ArticleStandard/Article/detail/633446?contextCategoryId=40237&ref=25 Hormone therapy used for the treatment of men with advanced prostate cancer is associated with an increased risk of developing various heart problems, according to findings from a study being called the largest and most comprehensive to examine this issue. 2009-10-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633446null HTML http://www.modernmedicine.com/modernmedicine/Endocrinology/Study-Evaluates-Hospital-Quality-and-Mortality-Rat/ArticleNewsFeed/Article/detail/633747?contextCategoryId=40237&ref=25 Hospital mortality rates in the United States have improved, although major differences in quality still exist between the best and worst hospitals, according to a report published Oct. 13 by HealthGrades. 2009-10-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747/hospitalsign_18169.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633747null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Mixed-Outcomes-Seen-for-Less-Invasive-Prostate-Sur/ArticleNewsFeed/Article/detail/633901?contextCategoryId=40237&ref=25 Although minimally invasive radical prostatectomy may be associated with some benefits compared to retropubic radical prostatectomy, it is also associated with more genitourinary complications, according to research published in the Oct. 14 issue of the Journal of the American Medical Association. 2009-10-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633901/surgeon_18066.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/422009/633901null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Combination-May-Improve-Prostate-Cancer-Prediction/ArticleNewsFeed/Article/detail/631560?contextCategoryId=40237&ref=25 Combining endorectal MRI, magnetic resonance spectroscopy, and a low free-to-total prostate-specific antigen ratio is highly accurate in predicting prostate cancer in men with high PSA levels, according to a European study in the October issue of Radiology. 2009-10-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631560/depressedman.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631560null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Procedure-May-Be-Helpful-in-Diagnosing-Prostate-Ca/ArticleNewsFeed/Article/detail/631258?contextCategoryId=40237&ref=25 Transurethral prostate resection may be a useful addition to prostate biopsy in detecting cancer in men whose prostate-specific antigen remains a concern after previous negative biopsies, according to research published in the October issue of the Journal of Urology. 2009-10-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631258/proscancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/631258null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Vessel-sealing-devices-safe-for-nerve-sparing-radi/ArticleStandard/Article/detail/633625?contextCategoryId=40237&ref=25 The temperature spread of blood vessel-sealing devices is limited during radical prostatectomy, meaning that these devices can be used safely for nerve-sparing procedures, provided that the right precautions are taken. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633625null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Enzyme-inhibitor-effective-against-refractory-pros/ArticleStandard/Article/detail/633623?contextCategoryId=40237&ref=25 In heavily pretreated men with castration-resistant prostate cancer, a specific and irreversible inhibitor of the enzyme CYP17 promotes declines in levels of PSA and the number of circulating tumor cells and an improvement in performance status. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633623null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Monoclonal-antibodies-show-antitumor-efficacy-in-p/ArticleStandard/Article/detail/633618?contextCategoryId=40237&ref=25 Two monoclonal antibodies have demonstrated antitumor activity in clinical trials of men with castrate-resistant prostate cancer. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633618null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/PCA3-Predictive-performance-superior-to-PSA-fPSA/ArticleStandard/Article/detail/633613?contextCategoryId=40237&ref=25 Researchers are further exploring the diagnostic and prognostic utility of PCA3, and data showed that combining PCA3 with free PSA and other risk factors significantly improves the accuracy for predicting biopsy outcomes. 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/422009/633613null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Research-Finds-Limited-Benefit-From-PSA-Test/ArticleNewsFeed/Article/detail/630505?contextCategoryId=40237&ref=25 Men should be aware of their chances of benefits and harms from prostate-specific antigen testing before the test, but many are not discussing screening before making the decision, according to the results of two studies in the Sept. 28 Archives of Internal Medicine. 2009-09-30T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/630505/physician_18134.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/630505null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Biopsy-Protocols-Compared-for-Prostate-Cancer-Dete/ArticleNewsFeed/Article/detail/629941?contextCategoryId=40237&ref=25 Twelve-core and eight-core biopsies have similar prostate cancer detection rates for initial biopsy, but the additional transition cores provided in 12-core biopsy may be helpful in detecting missed cancers in repeat biopsies, according to a study in the October issue of the Journal of Urology. 2009-09-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629941/29084.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629941null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Recurrence-of-Frank-Hematuria-Requires-Careful-Ass/ArticleNewsFeed/Article/detail/629719?contextCategoryId=40237&ref=25 In patients who have an initial episode of frank hematuria without a diagnosis, followed by a later recurrence, thorough evaluation is necessary due to a substantial risk of urological cancer, according to research published in the October issue of the Journal of Urology. 2009-09-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629719/urinespecimen_40025.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629719null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Socioeconomics-Play-Role-in-Prostate-Cancer-Mortal/ArticleNewsFeed/Article/detail/629722?contextCategoryId=40237&ref=25 Prostate cancer patients from low socioeconomic groups are more likely to die than their counterparts of high socioeconomic status, due to delayed diagnosis, poorer diagnostic methods and less invasive treatment, according to a study published online Sept. 28 in Cancer. 2009-09-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629722/shoulder_33304.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/629722null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Casts-Further-Doubt-on-PSA-for-Cancer-Screen/ArticleNewsFeed/Article/detail/629317?contextCategoryId=40237&ref=25 Based on likelihood ratios, prostate specific antigen concentrations at any cutoff value didn't meet the criteria needed for a screening test, according to research published online Sept. 24 in BMJ. 2009-09-25T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629317/stressedvet.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629317null XML http://www.modernmedicine.com/modernmedicine/Prostate+Cancer/Outcomes-improving-for-conservative-management-of-/ArticleStandard/Article/detail/627604?contextCategoryId=40237&ref=25 A comparison of outcomes of different eras of conservative treatment for localized prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from 1992 to 2002 compared with men diagnosed in the 1970s and 1980s. 2009-09-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/382009/627604null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Alcohol-Found-to-Lessen-Risk-for-Enlarged-Prostate/ArticleNewsFeed/Article/detail/629035?contextCategoryId=40237&ref=25 A man's risk of developing benign prostatic hyperplasia decreases as his consumption of alcohol increases, but not the risk of lower urinary tract symptoms, according to a meta-analysis reported in the October issue of the Journal of Urology. 2009-09-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629035/SS42069.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/629035null XML http://www.modernmedicine.com/modernmedicine/Enews/Weight-gain-in-adulthood-associated-with-prostate-/ArticleStandard/Article/detail/627606?contextCategoryId=40237&ref=25 Body mass in younger and older adulthood, and weight gain between these periods, may influence a man?s risk for prostate cancer, and the risk varies among different ethnic populations, report researchers from the University of Hawaii, Honolulu. 2009-09-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/382009/627606null HTML http://www.modernmedicine.com/modernmedicine/Enews/Researchers-find-virus-in-malignant-prostate-cance/ArticleStandard/Article/detail/627605?contextCategoryId=40237&ref=25 Researchers have reported that a virus known to cause leukemia and sarcomas in animals has been found in malignant human prostate cancer cells. 2009-09-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/382009/627605null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Conservative-Management-in-Prostate-Cancer-Feasibl/ArticleNewsFeed/Article/detail/626775?contextCategoryId=40237&ref=25 In older men with localized prostate cancer, conservative management is associated with significantly improved 10-year outcomes compared to earlier eras, according to a study published in the Sept. 16 issue of the Journal of the American Medical Association. 2009-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626775/proscancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626775null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Prostate-Stem-Cell-May-Be-a-Source-of-Cancer/ArticleNewsFeed/Article/detail/626206?contextCategoryId=40237&ref=25 A new type of prostate stem cell isolated from adult mice may be a source of prostate cancer, according to a study published online Sept. 9 in Nature. 2009-09-14T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626206/lab_18097.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382009/626206null XML http://urologytimes.modernmedicine.com/urologytimes/Enews/Hormone-therapy-in-men-with-PCa-heart-conditions-r/ArticleStandard/Article/detail/624301?contextCategoryId=40237&ref=25 Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to researchers at Brigham & Women's Hospital-Dana Farber Cancer Institute, Boston. 2009-09-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362009/624301null HTML http://www.modernmedicine.com/modernmedicine/Enews/Prostate-cancer-overdiagnosis-attributed-to-PSA-te/ArticleStandard/Article/detail/624305?contextCategoryId=40237&ref=25 Since its introduction in 1986, PSA screening has resulted in more than one million men being needlessly diagnosed and treated for prostate cancer, according to a study published online Aug. 31 in the Journal of the National Cancer Institute. 2009-09-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362009/624305null HTML http://www.modernmedicine.com/modernmedicine/Enews/Obesity-increases-risk-of-prostate-cancer-recurren/ArticleStandard/Article/detail/624328?contextCategoryId=40237&ref=25 Obesity plays no favorites when it comes to increasing the risk of prostate cancer recurrence after surgery, according to researchers at Duke University Medical Center, Durham, NC. Being overweight is equally bad for African-American and white men. 2009-09-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362009/624328null HTML http://www.modernmedicine.com/modernmedicine/Enews/NCCN-guidelines-stress-importance-of-PSA-testing-i/ArticleStandard/Article/detail/624330?contextCategoryId=40237&ref=25 In high-risk men, PSA testing performs optimally when conducted intelligently and combined with prompt, effective, high-quality treatment, according to updated clinical practice guidelines on early detection of prostate cancer from the National Comprehensive Cancer Network. 2009-09-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362009/624330null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-Cancer-Patients-Seek-Several-Information-/ArticleNewsFeed/Article/detail/624312?contextCategoryId=40237&ref=25 Between diagnosis of local stage prostate cancer and treatment, men access an average of five information sources, according to a study published in the September issue of Urology. 2009-09-04T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624312/asian_man.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624312null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Findings-Support-Deferred-Prostate-Cancer-Treatmen/ArticleNewsFeed/Article/detail/624146?contextCategoryId=40237&ref=25 Some men with prostate cancer may safely defer treatment for years without a higher risk of metastasis or cancer mortality than those who receive initial treatment, according to research published online Aug. 31 in the Journal of Clinical Oncology. 2009-09-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624146/balding_fac088.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624146null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Diagnoses-Health-Costs-Rise-in-Partners-of-Cancer-/ArticleNewsFeed/Article/detail/624030?contextCategoryId=40237&ref=25 Health care use increases in partners of cancer patients following the cancer diagnosis, according to research published online Aug. 31 in the Journal of Clinical Oncology. 2009-09-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624030/fac087.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/624030null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Body-Mass-Weight-Gain-Linked-to-Prostate-Cancer-Ri/ArticleNewsFeed/Article/detail/623793?contextCategoryId=40237&ref=25 Men's body mass, as well as weight gain in adulthood, may affect their risk of prostate cancer, according to research published online Sept. 1 in Cancer Epidemiology, Biomarkers & Prevention. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623793/manstomachsmall.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623793null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/High-intensity-focused-ultrasound-shows-acceptable/ArticleStandard/Article/detail/624478?contextCategoryId=40237&ref=25 A single session of high-intensity focused ultrasound as primary therapy for localized prostate cancer results in an acceptable rate of biochemical-free recurrence. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624478null XML http://www.modernmedicine.com/modernmedicine/Urology/Cardiometabolic-Disorders-amp-Weight-Action-for-Ou/ArticleStandard/Article/detail/623705?contextCategoryId=40237&ref=25 For the first time, 17 of Advanstar Communications' Life Sciences publications and its web portal, ModernMedicine.com, are collaborating in a coordinated, interdisciplinary initiative to address a major public health issue: cardiometabolic disorders and weight. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/362009/623705null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laparoscopic-radical-prostatectomy-Cure-is-more-li/ArticleStandard/Article/detail/624475?contextCategoryId=40237&ref=25 Laparoscopic radical prostatectomy has a definite learning curve, but it is slower than the learning curve for open surgery and is worsened in surgeons with prior open training. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624475null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Neoadjuvant-chemo-combo-no-silver-bullet-in-prosta/ArticleStandard/Article/detail/624480?contextCategoryId=40237&ref=25 In a phase II study, about 40% of men with clinically localized, high-risk prostate cancer were free of biochemical recurrence at 18 months when treated with neoadjuvant docetaxel (Taxotere) and ketoconazole followed by surgical excision, according to research presented at the AUA annual meeting. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624480null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Radiation-dose-key-to-lasting-brachytherapy-effect/ArticleStandard/Article/detail/624461?contextCategoryId=40237&ref=25 Permanent brachytherapy's long-term success depends on delivery of a high biological effective dose of radiation. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624461null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-tool-may-improve-quality-of-life-assessment-in/ArticleStandard/Article/detail/624470?contextCategoryId=40237&ref=25 A new computerized tool may solve the problem of the time and effort it takes to have patients fill out forms to assess quality of life. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624470null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Studies-High-intensity-focused-ultrasound-yields-s/ArticleStandard/Article/detail/624479?contextCategoryId=40237&ref=25 Two of several studies presented by the same international team suggest that high-intensity focused ultrasound provides good biochemical-free survival at 5 years in patients treated in the absence of hormone therapy. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624479null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Brachytherapy-vs-radical-prostatectomy-Efficacy-is/ArticleStandard/Article/detail/624486?contextCategoryId=40237&ref=25 Brachytherapy and radical prostatectomy are effective treatments for localized prostate cancer, but have different long-term functional effects, 13-year follow-up data show. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624486null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/PSA-kinetics-Not-a-reliable-signal-to-intervene/ArticleStandard/Article/detail/624463?contextCategoryId=40237&ref=25 PSA velocity and PSA doubling time, once considered promising tools for identifying the need for intervention in prostate cancer patients under active surveillance, now appear to have failed to meet that promise. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624463null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-Specific-Antigen-Test-May-Increase-Overdi/ArticleNewsFeed/Article/detail/623317?contextCategoryId=40237&ref=25 Since the prostate-specific antigen test was introduced, many men have been overdiagnosed with prostate cancer, according to a study published online Aug. 31 in the Journal of the National Cancer Institute. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623317/depressedman.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623317null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Full-partial-cryoablation-Good-5-year-outcomes/ArticleStandard/Article/detail/624469?contextCategoryId=40237&ref=25 Two large studies of cryoablation for prostate cancer showed positive disease-free rates. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624469null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Neoadjuvant-hormonal-therapy-yields-no-difference-/ArticleStandard/Article/detail/624489?contextCategoryId=40237&ref=25 Despite bringing lower rates of positive surgical margins and lower PSA nadirs, long-term neoadjuvant hormonal therapy did not lead to a difference in rates of PSA recurrence after 7 years. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624489null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Three-fourths-of-men-with-prostate-cancer-may-be-e/ArticleStandard/Article/detail/624472?contextCategoryId=40237&ref=25 Due to PSA screening practices in the U.S., three-fourths of American men with prostate cancer may be eligible for focal ablation. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624472null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Clinical-use-of-urine-PCA3-mRNA-testing/ArticleStandard/Article/detail/624481?contextCategoryId=40237&ref=25 Discovery of the prostate carcinoma-specific gene has led to the development of a promising urine-based laboratory test for the disease. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624481null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Agent-markedly-improves-bone-mineral-density-in-an/ArticleStandard/Article/detail/624482?contextCategoryId=40237&ref=25 Twice-yearly injections of denosumab improved bone mineral density in men with prostate cancer treated with androgen deprivation therapy. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624482null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Estrogen-receptor-modulator-reduces-ADT-fractures/ArticleStandard/Article/detail/624483?contextCategoryId=40237&ref=25 Androgen deprivation therapy leads to an increased risk of bone fractures and other side effects of estrogen deficiency in men with prostate cancer, but those effects can be successfully treated with the use of an oral selective estrogen receptor modulator, suggest the results of a large, prospective, randomized tria presented at the AUA annual meeting in Chicago. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/372009/624483null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Radiation-Therapy-Fatigue-Linked-to-Cytokine-Netwo/ArticleNewsFeed/Article/detail/622068?contextCategoryId=40237&ref=25 In patients who receive radiation treatment for early-stage breast or prostate cancer, the resulting fatigue may be associated with activation of the proinflammatory cytokine network, according to a study published online Aug. 25 in Clinical Cancer Research 2009-08-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352009/622068/Fac045ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352009/622068null XML http://www.modernmedicine.com/modernmedicine/Enews/Anxiety-often-kept-at-bay-in-men-with-early-stage-/ArticleStandard/Article/detail/620874?contextCategoryId=40237&ref=25 Elevated anxiety and distress levels don?t appear to be present in men with early stages of prostate cancer who wait to pursue radical treatment and instead opt for expectant management, a recently published study has found. 2009-08-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/342009/620874null HTML http://www.modernmedicine.com/modernmedicine/Enews/FDA-panel-gives-nod-to-bone-loss-drug-used-in-pros/ArticleStandard/Article/detail/620870?contextCategoryId=40237&ref=25 The FDA Advisory Committee for Reproductive Health Drugs (ACRHD) has recommended approval of denosumab (Prolia) for prevention and treatment of bone loss in certain prostate cancer patients. 2009-08-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/342009/620870null HTML http://www.modernmedicine.com/modernmedicine/Endocrinology/Hormones-Hike-Death-Risk-in-Some-Prostate-Cancers/ArticleNewsFeed/Article/detail/621480?contextCategoryId=40237&ref=25 Men with prostate cancer who receive neoadjuvant hormone therapy in combination with radiotherapy face an increased all-cause mortality risk if they have significant cardiovascular comorbidities, including congestive heart failure or prior myocardial infarction, according to a study reported in the Aug. 26 issue of the Journal of the American Medical Association. 2009-08-25T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352009/621480/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352009/621480null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Clodronate-Improves-Survival-in-Advanced-Prostate-/ArticleNewsFeed/Article/detail/619072?contextCategoryId=40237&ref=25 Sodium clodronate improves overall survival in men with metastatic prostate cancer, but it does not reduce the risk of death in men with non-metastatic prostate cancer, according to a study published online Aug. 11 in The Lancet Oncology. 2009-08-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/619072/fac053.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/619072null XML http://www.modernmedicine.com/modernmedicine/News/Cancer-related-mortality-remains-low-long-after-ra/ArticleStandard/Article/detail/617720?contextCategoryId=40237&ref=25 In the 15 years following a radical prostatectomy, there is only a 12% mortality rate directly connected to prostate cancer, regardless of the cancer?s aggressiveness, according to a multicenter study appearing in the Journal of Clinical Oncology online. Comparatively, there was a 38% rate of non-cancer-related death in this same group of patients. 2009-08-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/332009/617720null HTML http://www.modernmedicine.com/modernmedicine/Enews/Prostate-cancer-screening-linked-to-physician-pati/ArticleStandard/Article/detail/617735?contextCategoryId=40237&ref=25 The better the relationship is between men and their health care provider, the greater their chance of receiving prostate cancer screening and the less likely they are to be diagnosed with advanced prostate cancer, regardless of their race, researchers from the University of North Carolina, Chapel Hill, and Roswell Park Cancer Institute, Buffalo, NY, reported in Cancer online. 2009-08-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/332009/617735null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/More-Research-Links-Alcohol-Intake-to-Cancer-Risk/ArticleNewsFeed/Article/detail/617970?contextCategoryId=40237&ref=25 Men who drink moderate or high amounts of alcohol over their lifetime may face a higher risk of several types of cancer, according to research published in the current issue of Cancer Detection and Prevention. 2009-08-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/617970/SS42042.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/332009/617970null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/3D-Prostate-Mapping-Biopsy-Shows-Staging-Accuracy/ArticleNewsFeed/Article/detail/617421?contextCategoryId=40237&ref=25 Three-dimensional prostate mapping biopsy may provide better accuracy in staging prostate cancer, which could have a major effect on patients' outcomes, according to research published online Aug. 3 in the Journal of Clinical Oncology. 2009-08-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617421/physician_18134.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/617421null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Gene-Variant-Linked-to-Urinary-Bladder-Cancer/ArticleNewsFeed/Article/detail/616017?contextCategoryId=40237&ref=25 A variant of a gene initially identified through its overexpression in prostate cancers is also associated with bladder cancers, according to a study published online Aug. 2 in Nature Genetics. 2009-08-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/616017/genetics_MIC028ML.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/616017null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Cure-rate-of-80-seen-with-male-sling/ArticleStandard/Article/detail/614288?contextCategoryId=40237&ref=25 A non-bone-anchored male sling appears to resolve mild to moderate post-prostatectomy incontinence in up to 80% of patients and may also lead to significant improvement in erectile and sexual function. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614288null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-radical-prostatectomy-expectations-about-sexu/ArticleStandard/Article/detail/614300?contextCategoryId=40237&ref=25 A significant number of patients undergoing open or robotic radical prostatectomy have unrealistic expectations about postoperative sexual function. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614300null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Base-International-Index-of-Erectile-Function-scor/ArticleStandard/Article/detail/614286?contextCategoryId=40237&ref=25 A study by psychologists and urologists has found that factors affecting erectile function after prostatectomy have much the same impact after other prostate cancer treatments. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614286null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Post-radical-prostatectomy-margin-location-may-aff/ArticleStandard/Article/detail/614289?contextCategoryId=40237&ref=25 A solitary positive apical margin following radical prostatectomy is associated with a higher biochemical recurrence rate than are negative surgical margins., but positive apical margins are associated with a lower recurrence rate than non-apical or multifocal positive margins are. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614289null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Radiotherapy-well-tolerated-in-pre-radical-prostat/ArticleStandard/Article/detail/614283?contextCategoryId=40237&ref=25 Planned radical prostatectomy within 8 weeks of preoperative radiotherapy is well tolerated and may result in downstaging of the disease, according to results of a phase I study. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614283null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Lower-payment-not-only-factor-in-dropping-LHRH-usa/ArticleStandard/Article/detail/614301?contextCategoryId=40237&ref=25 The substantial decrease in the use of LHRH agonists in the U.S. since 2004 may not be entirely explained by a recent reduction in physician reimbursement. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/312009/614301null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Long-Term-Risk-of-Death-After-Radical-Prostatectom/ArticleNewsFeed/Article/detail/615292?contextCategoryId=40237&ref=25 A model developed to predict the 15-year risk of dying of prostate cancer after radical prostatectomy shows that the risk is very low, particularly in more recent patients treated in the era of widespread prostate-specific antigen screening, according to a study published online July 27 in the Journal of Clinical Oncology. 2009-07-30T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/615292/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/615292null XML http://www.modernmedicine.com/modernmedicine/Enews/PCa-therapies-among-top-priorities-for-effectivene/ArticleStandard/Article/detail/613519?contextCategoryId=40237&ref=25 Treatments for prostate cancer are among 100 health topics that should receive priority attention and funding from a new national research effort to identify which health care services are most effective. 2009-07-30T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/302009/613519null HTML http://www.modernmedicine.com/modernmedicine/Enews/Three-generic-formulations-of-prostate-cancer-trea/ArticleStandard/Article/detail/613539?contextCategoryId=40237&ref=25 Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, and Sandoz Inc. have received FDA approval for their generic formulations of bicalutamide tablets, 50 mg. 2009-07-30T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/302009/613539null HTML http://www.modernmedicine.com/modernmedicine/Endocrinology/Older-Cancer-Survivors-Report-Good-Quality-of-Life/ArticleNewsFeed/Article/detail/614692?contextCategoryId=40237&ref=25 Older long-term cancer survivors rate their quality of life better than the norms for their age despite a tendency to poor health behaviors, according to a study published online July 27 in Cancer. 2009-07-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614692/FAC030.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614692null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stress-Levels-With-Prostate-Active-Surveillance-Me/ArticleNewsFeed/Article/detail/614693?contextCategoryId=40237&ref=25 Most men with early prostate cancer who are following the active surveillance protocol are generally able to manage the mental stress of their situation very well; factors such as a neurotic personality score, high prostate-specific antigen, and poor health are associated with increased anxiety, according to a study published online July 27 in Cancer. 2009-07-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614693/stressedvet.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614693null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostate-Cancer-Vaccine-Elicits-Immune-Response/ArticleNewsFeed/Article/detail/614694?contextCategoryId=40237&ref=25 A vaccine against a prostate tumor antigen is safe, elicits an immune response, and may increase prostate-specific antigen doubling time in patients with recurrent prostate cancer, according to an early-stage study published online July 27 in the Journal of Clinical Oncology. 2009-07-28T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614694/injection_18314.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/614694null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Treatment-Can-Reduce-Bone-Turnover-in-Prostate-Can/ArticleNewsFeed/Article/detail/613459?contextCategoryId=40237&ref=25 Treatment of bone metastases in prostate cancer patients with denosumab, which blocks bone resorption, reduces bone turnover compared with bisphosphonates, according to a study in the August issue of the Journal of Urology. 2009-07-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613459/OSTEO.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/613459null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Baseline-Function-Can-Affect-Change-After-Prostate/ArticleNewsFeed/Article/detail/612714?contextCategoryId=40237&ref=25 The long-term effect of prostate cancer treatments on men's sexual, bowel, and urinary function depends on patients' baseline levels of function, according to research published online July 20 in the Journal of Clinical Oncology. 2009-07-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612714/depressedman.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612714null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Multidisciplinary-Approach-Recommended-for-Pelvic-/ArticleNewsFeed/Article/detail/612330?contextCategoryId=40237&ref=25 In a commentary on three diverse studies in the August Journal of Urology, a leading urologist advocates a multidisciplinary approach to unravel the complex pathologies of pelvic pain, prostatitis, painful bladder syndrome, and interstitial cystitis. 2009-07-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612330/pelvis_59279.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612330null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Depression-Insomnia-Affect-Many-Prostate-Cancer-Pa/ArticleNewsFeed/Article/detail/612328?contextCategoryId=40237&ref=25 Many men with prostate cancer suffer from insomnia, depression and distress, and younger men as well as those receiving radiation therapy are most at risk, according to a study published the August issue of Applied Nursing Research. 2009-07-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612328/proscancer.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612328null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Obesity-Not-an-Obstacle-for-Prostate-Specific-Anti/ArticleNewsFeed/Article/detail/612448?contextCategoryId=40237&ref=25 A patient's weight does not significantly affect the usefulness of prostate specific antigen testing to determine prostate cancer, according to a study in the August issue of the Journal of Urology. 2009-07-20T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612448/manstomachsmall.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612448null XML http://www.modernmedicine.com/modernmedicine/Enews/Drug-targeting-BRCA-gene-mutations-shows-promise-i/ArticleStandard/Article/detail/610300?contextCategoryId=40237&ref=25 Patients with inherited forms of advanced prostate, breast, and ovarian cancers caused by mutations in the BRCA1 and BRCA2 genes experienced tumor shrinkage without major side effects when treated with the investigational drug olaparib (AZD-2281), a recently published phase I study showed. 2009-07-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/282009/610300null HTML http://www.modernmedicine.com/modernmedicine/Enews/Brachytherapy-Patients-who-are-disease-free-at-5-y/ArticleStandard/Article/detail/610303?contextCategoryId=40237&ref=25 Prostate cancer patients who receive brachytherapy and remain free of disease for 5 years are unlikely to have a recurrence at 10 years, according a new study by researchers from Mount Sinai Medical Center, New York. 2009-07-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/urologytimes/282009/610303null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Combination-Therapy-Can-Cut-Prostate-Cancer-Death-/ArticleNewsFeed/Article/detail/611741?contextCategoryId=40237&ref=25 The risk of death from prostate cancer is lower for patients treated with brachytherapy supplemented by external-beam radiation therapy and androgen suppression therapy than it is for those treated with brachytherapy alone, according to a study published online July 13 in the Journal of Clinical Oncology. 2009-07-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/611741/prostate.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/611741null XML